Cirle, a Miami-based medical technology company, announced the appointment of Richard W. D’Souza to the newly created position of president. D’Souza will oversee the company’s current R&D and engineering efforts as well as develop a pipeline of future opportunities.
D’Souza has more than 25 years of experience in bringing products to the global marketplace. D’Souza has launched dozens of prescription, OTC, consumer and medical devices products with Valeant Pharmaceuticals, Bausch & Lomb, Johnson & Johnson, Pfizer Inc./Warner Lambert and Procter & Gamble.
In April 2014, Cirle announced that it had entered into an exclusive license agreement with Bausch + Lomb, the global eye-health company, for development and commercialization of the Cirle Surgical Navigation System for cataract surgery.
“We are very fortunate that an industry leader with Richard’s product development track record, commercial insight and extensive relationships has agreed to help ensure the success of the next stage of Cirle’s growth,” said Richard M. Awdeh, M.D., founder and CEO of Cirle, which was founded in 2010. “D’Souza will be instrumental in advancing development of our first licensed application for the Cirle Surgical Navigation System, while working with us to expand that platform and pursue other technologies to build a robust product pipeline.”
D'Souza said he was attracted to Cirle and the startup life in part because Cirle's lead product is based on a technology platform that offers additional potential applications in ophthalmology as well as other organ systems.
Cirle, focused on curing diseases that lead to blindness through the use of translational medical research and technologies, develops and acquires early stage technologies and pursues industry collaborations to bring them to market.